Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Are there studies looking at Ra-223 and SBRT for oligometastatic disease in the setting of mCRPC?
Answer from: Radiation Oncologist at Community Practice
Yes, quite a few including one from UCLA- NCT05496959
Sign in or Register to read more
18046
Related Questions
How do you counsel/advise patients when asked to compare ultrahypofractionated radiotherapy with the TULSA procedure?
Which patients, if any, do you offer transdermal estradiol as a method of ADT instead of LHRH agonists?
Do you offer RT both to the prostate and synchronous oligometastases in de novo oligometastatic prostate cancer?
Does long term use of 5 alpha reductase inhibitors change the way you evaluate a PSMA PET?
How do you incorporate absolute percent pattern 4 (APP4) into your risk stratification, specifically your recommendation for ADT for intermediate prostate cancer?
Is there any evidence for combining surgery and XRT +/- ADT for treatment of localized high risk prostate cancer?
Why is there a benefit of ADT for high risk prostate cancer treated with radiation, yet no large trials describing benefit of adjuvant ADT after radical prostatectomy?
How do you approach rising PSA following radical prostatectomy and early salvage radiation therapy?
Do you utilize daily enemas for patients undergoing prostate SBRT?
For a patient with stage IIB pure seminoma s/p orchiectomy who has bilateral RP adenopathy, do you also cover the contralateral iliac nodes in the dog-leg field?